![Mind & Matter artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts114/v4/ee/1d/85/ee1d8570-3f8d-7e4d-8473-ec87c6217364/mza_14049096579641923890.jpg/100x100bb.jpg)
Lisa Monteggia: Ketamine, Depression, SSRIs, Neuropsychiatric Disorders & the Brain | #29
Mind & Matter
English - July 09, 2021 04:00 - 1 hour - 63.7 MB - ★★★★★ - 15 ratingsScience Society & Culture science drugs psychedelics technology biotechnology innovation biology brain neuroscience startups Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Nick talks to neuroscientist Dr. Lisa Monteggia about research on psychiatric disorders of the brain. Lisa described how psychiatric disorders like depression manifest in the brain, how traditional anti-depressant drugs like SSRIs work in the brain, and her research on how the drug ketamine can have rapid depressant effects in treatment-resistant patients.
SUPPORT
Support the show on Patreon
Sign up for the weekly Mind & Matter newsletter (check your spam folder on Friday)
Organize your digital highlights & notes w/ Readwise (2 months free w/ subscription)
Start your own podcast (get $20 Amazon gift card after signup)
Buy Mind & Matter t-shirts
Connect with Nick Jikomes on Twitter
Download the podcast & follow Nick at his website
SPONSORS
Learn more about our podcast sponsor, Dosist
ABOUT Nick Jikomes:
Nick is a neuroscientist and podcast host. He is currently Director of Science & Innovation at Leafly, a technology startup in the legal cannabis industry. He received a Ph.D. in Neuroscience from Harvard University and a B.S. in Genetics from the University of Wisconsin-Madison.
Support the show (https://www.patreon.com/nickjikomes)